1,6-Octadiene, 8-methoxy-
Common Name: |
1,6-Octadiene, 8-methoxy- |
IUPAC Name: |
8-methoxyocta-1,6-diene |
Molecular Formula: |
C9H16O |
SMILES: |
COCC=CCCCC=C |
Inchi: |
1S/C9H16O/c1-3-4-5-6-7-8-9-10-2/h3,7-8H,1,4-6,9H2,2H3 |
Inchi Key: |
MIJJHRIQVWIQGL-UHFFFAOYSA-N |
Cas No: |
14543-49-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
140.22 |
Mass (g/mol) |
140.12 |
Molar Refractivity |
45.51 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
6 |
Rings |
|
TPSA |
9.23 |
Hetero Atoms |
1 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
176.64 |
Vapor Pressure (mmHg@25.00 °C) |
1.456 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.56 |
LogP |
2.545 |
iLOGP |
2.82 |
XLOGP3 |
2.50 |
WLOGP |
2.55 |
MLOGP |
2.28 |
ESOL Log S |
-1.89 |
ESOL Solubility (mg/ml) |
1.81 |
ESOL Solubility (mol/l) |
0.013 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.34 |
Ali Solubility (mg/ml) |
0.64 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.14 |
Silicos-IT Solubility (mg/ml) |
1.03 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.38 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.941 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.483 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
1 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |